Plunkett's Biotech & Genetics Industry Almanac 2007 : Market Research Report

Plunkett's Biotech & Genetics Industry Almanac 2007

Published by: Plunkett Research, Ltd.

Published: Aug. 20, 2007 - 590 Pages

A Short Biotech & Genetics Industry Glossary
Introduction
How to Use This Book
Chapter 1: Major Trends Affecting the Biotech & Genetics Industry: 1) A Short History of Biotechnology; 2) The State of the Biotechnology Industry Today; 3) Ethanol Use Grows Quickly; 4) New Money Pours into Biotech Firms; 5) Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms; 6) From India to Singapore to China, Nations Compete Fiercely in Biotech Development; 7) Gene Therapies and Patients’ Genetic Profiles Promise a Personalized Approach to Medicine; 8) New Kinase Inhibitors Are Breakthrough Drugs for Cancer Treatment—Many More Will Follow; 9) Pharmaceutical Costs Soar in U.S., Controversy over Drug Prices Rages On; 10) Biotech Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age; 11) Biogenerics are in Limbo in the U.S.; 12) Breakthrough Drug Delivery Systems Evolve; 13) Stem Cells—Controversy in the U.S. Threatens to Leave America Far Behind in the Research Race; 14) Stem Cell Funding Trickles in the U.S. at the Federal Level While a Few States Create Funding of Their Own; 15) Stem Cells—Therapeutic Cloning Techniques Advance; 16) Stem Cells—A New Era of Regenerative Medicine Looms; 17) Nanotechnology Converges with Biotech; 18) Agricultural Biotechnology Scores Breakthroughs but Causes Controversy/Selective Breeding Offers a Compromise; 19) Focus on Vaccines to Counter Potential Bioterror Attacks in the U.S.; 20) Ethical Issues Abound; 21) Technology Discussion—Genomics; 22) Technology Discussion—Proteomics; 23) Technology Discussion—Microarrays; 24) Technology Discussion—DNA Chips; 25) Technology Discussion—SNPs (“Snips”); 26) Technology Discussion—Combinatorial Chemistry; 27) Technology Discussion—Synthetic Biology; 28) Technology Discussion—Recombinant DNA; 29) Technology Discussion—Polymerase Chain Reaction (PCR)
Chapter 2: Biotech & Genetics Industry Statistics: Biotech Industry Overview; Global Biotechnology at a Glance: 2006; Growth in Global Biotechnology: 2005-2006; Biotechnology Financing, U.S., Europe & Canada: 2005-2006; U.S. Biotechnology at a Glance: 2005-2006; Quarterly Breakdown of Biotechnology Financings, U.S. & Canada: 2006; Ernst & Young Survival Index, U.S. & Canadian Biotechnology Companies: 2005-2006; Global Area of Biotech Crops by Country: 2006; Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2005; Plant-Derived Pharmaceuticals for the Treatment of Human Diseases that are in the Pipeline for Commercialization: 2007; The U.S. Drug Discovery & Approval Process; U.S. FDA Approval Times for New Drugs: 1993-2006; U.S. FDA Approval Times for New Molecular Entities (NMEs): 1993-2006; Domestic Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1970-2006; Domestic Biopharmaceutical R&D Breakdown, PhRMA Member Companies: 2005; R&D By Global Geographic Area, PhRMA Member Companies: 2005; R&D as a Percentage of U.S. Biopharmaceutical Sales, PhRMA Member Companies: 1970-2006; U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1993-2006; Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1970-2006; Domestic & Foreign Pharmaceutical Sales by End Use & Customer, PhRMA Member Companies: 2005; Generics' Share of the U.S. Drug Market by Volume: 1984-2007; National Health Expenditure Amounts by Type of Expenditure, U.S.: Selected Calendar Years, 2001-2016; Prescription Drug Expenditures, U.S.: 1965-2016; U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: Selected Calendar Years, 2001-2016; 20 Largest Global Pharmaceutical Companies: 2005-2006; Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Year 2006-2008; Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2005-2007; Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2006; Domestic Biopharmaceutical R&D Scientific, Professional, and Technical Personnel by Function, PhRMA Member Companies: 2005
Chapter 3: Important Biotech & Genetics Industry Contacts: (Addresses, Phone Numbers and World Wide Web Sites)
Chapter 4: THE BIOTECH 400: Who They Are and How They Were Chosen: Industry Codes; Index of Rankings Within Industry Groups; Alphabetical Index; Index of Headquarters Location by U.S. State; Index of Non-U.S. Headquarters Location by Country; Index by Regions of the U.S. Where the Firms Have Locations; Index by Firms with Operations Outside the U.S.; Individual Profiles on Each of THE BIOTECH 400
Additional Indexes: Index of Hot Spots for Advancement for Women/Minorities; Index by Subsidiaries, Brand Names and Selected Affiliations

Abstract

Plunkett's Biotech & Genetics Industry Almanac 2007 is a complete reference guide to the business side of biotechnology, genetics, proteomics and related services. This new book contains complete profiles of the leading biotech companies, in-depth chapters on trends in genetics, technologies, statistics and finances, a handy glossary and thorough indexes. Plunkett's Biotech & Genetics Industry Almanac, our easy-to-understand reference to the biotech and genetics industry, is an absolutely vital addition to your office. For the first time, in one carefully-researched volume, you'll get all of the data you need. Topics include: A Short History of Biotechnology; The State of the Biotechnology Industry Today; Biotechnology funding and investments; Patents; Biotech activities in Singapore and China; FDA; Gene Therapies; Personalized Medicine; Systems Biology; Drug Development; Clinical Trials; Controversy over Drug Prices; Stem Cells Research; Therapeutic Cloning; Regenerative Medicine Nanotechnology; Agricultural Biotechnology; Drug Delivery Systems; BioShield; Ethical Issues. The book also includes complete profiles on over 400 Biotech & Genetics companies, our own unique list of companies that are the leaders in biotechnology. These are the largest, most successful corporations in all facets of this exploding business. All of the corporate profile information is indexed and cross-indexed, including contact names, addresses, Internet addresses, fax numbers, toll-free numbers, plus growth and hiring plans, finances, research, marketing, technology, acquisitions and much more for each firm..

*Clients who purchase the online download version of this report should use the form provided in the report to receive the database of leading companies on CD-ROM.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

advertise with us

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Plunkett's Biotech & Genetics Industry Almanac 2007

Table of Contents

Abstract